UDG Healthcare plc announced the appointment of Mr. Peter Chambre and Mr. Shane Cooke as non-executive directors of the company with effect from 1 February 2019. Peter is currently Chairman of Immatics Biotechnologies GmbH. He is a Trustee of Cancer Research UK since 2016. Shane Cooke has extensive experience in the pharmaceutical and life sciences sectors in both Europe and the United States and is currently a non-executive director of Alkermes plc, having previously held the position of President from September 2011 until his retirement in March 2018. Prior to this, Shane spent 10 years as Chief Financial Officer of Elan Corporation plc from 2001 and from 2007 he also was Head of Elan Drug Technologies.